In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Center To Add Program For Joint Planning Of PMA Submissions

This article was originally published in The Gray Sheet

Executive Summary

The Center for Devices and Radiological Health is planning to offer a new type of meeting in which sponsors and FDA reviewers agree on content and format of a premarket application submission

You may also be interested in...



CMS Coverage Policy, IT Programs Foster Information Transfer – Tunis

CMS input during a company's clinical research design process could set the stage for more effective information transfer as the technology moves past the regulatory process into clinical practice, CMS Acting Chief Medical Officer Sean Tunis suggested at an "evidence-based innovations" healthcare conference Jan. 27 in Washington, D.C

CMS Coverage Policy, IT Programs Foster Information Transfer – Tunis

CMS input during a company's clinical research design process could set the stage for more effective information transfer as the technology moves past the regulatory process into clinical practice, CMS Acting Chief Medical Officer Sean Tunis suggested at an "evidence-based innovations" healthcare conference Jan. 27 in Washington, D.C

Earlier OST Involvement In Device Lifecycle Is Potential User Fee Impact

Medical device user fees could spur the Office of Science & Technology to become involved with reviews earlier in the device lifecycle, CDRH topsiders suggest

Related Content

UsernamePublicRestriction

Register

MT016724

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel